Doximity Shares Jump 25% After Beating Q3 Revenue Forecasts and Raising Full-Year Guidance

Doximity shares surged 25% in extended trading Thursday after the company exceeded analysts’ third-quarter fiscal 2025 revenue expectations and raised its full-year guidance. The company reported higher-than-expected revenue and increased net income than the previous year. Doximity is a digital platform that provides medical professionals with tools for staying informed, managing paperwork, and conducting telehealth appointments. The company earns revenue through telehealth services, hiring solutions, and marketing offerings for pharmaceutical clients. CEO Jeff Tangney highlighted record engagement, with AI tools growing 60% quarter-over-quarter.